Vulva carcinoma is a cancer that starts in the outer female genital area, and it most often affects older adults. Early symptoms of vulva carcinoma can include ongoing itching, pain, burning, bleeding, or a sore or lump that does not heal. Not everyone will have the same experience. Vulva carcinoma can be serious and sometimes life-threatening, but many people do well when it is found early and treated. Treatment often includes surgery, and some people also need radiation therapy, chemotherapy, or medicines that target the cancer.
How many people live with Vulva carcinoma?
Worldwide, about 160,000 women were living with vulvar cancer in 2022 after being diagnosed sometime in the previous 5 years (GLOBOCAN, 2022). In the United States, the comparable estimate was about 24,000 women (GLOBOCAN, 2022).
Overview
Vulva carcinomaSymptoms
Vulva carcinoma often causes ongoing itching, burning, pain, or a sore or lump on the vulva that does not heal. Some notice bleeding, skin color changes, or pain during urination or sex.
Outlook and prognosis
The outlook for vulva carcinoma is often good when it is found early and treated before it spreads to nearby lymph nodes. Even with more advanced vulva carcinoma, treatment can still control the cancer, ease symptoms, and help many people live longer.
Causes and risk factors
Vulva carcinoma is linked to long-term human papillomavirus infection or chronic vulvar skin disease. Risk rises with older age, smoking, a weakened immune system, and past cervical changes. Some cases occur without a clear cause.
Genetic influences
Genetics matter in vulva carcinoma, but most cases are not strongly inherited. Some gene changes in the tumor can help guide treatment, while inherited risk is usually limited and only becomes more relevant when there is a strong family history.
Diagnosis
Vulva carcinoma is usually diagnosed with a pelvic exam and a small tissue sample, called a biopsy. Imaging tests may help show the size of the cancer and whether it has spread.
Treatment and drugs
Treatment for vulva carcinoma often includes surgery to remove the cancer, sometimes with nearby lymph nodes. Depending on the stage, radiation therapy and chemotherapy may also help. Many people with vulva carcinoma need ongoing follow-up to watch for recurrence.
Symptoms
Vulva carcinoma can show up as ongoing itching, irritation, pain, or a sore or patch of skin on the vulva that does not heal. The changes are often subtle at first, blending into daily life until they become more noticeable. In medical terms, this is vulva carcinoma; in everyday life, it may feel like a persistent skin problem that keeps coming back or slowly worsens.
Persistent itching, burning, or rawness around the vulva is one of the most common symptoms. Early symptoms of vulva carcinoma can look like irritation that does not settle with usual skin care or treatment.
The skin may become thicker, lighter, darker, redder, or rougher than usual. Some people notice a patch that looks different from the surrounding skin and stays there.
A new lump, raised area, or wart-like growth on the vulva can be a warning sign. It may be painless at first, which is one reason it can be easy to ignore.
An open sore, cracked area, or ulcer that does not heal deserves medical attention. Many living with vulva carcinoma notice that the spot lingers for weeks or slowly gets larger.
How people usually first notice Vulva carcinoma?
Vulva carcinoma is often first noticed when a sore, lump, patch of skin, or area of thickening on the vulva does not go away and may slowly start to change in color, texture, or size. Many people living with vulva carcinoma first seek care because of ongoing itching, burning, pain, spotting or bleeding not linked to a period, or discomfort during urination or sex. These symptoms can also happen with much more common, noncancerous vulvar conditions, but if they last more than a few weeks or keep coming back, it is important to have them checked.
Types of Vulva carcinoma
The main types of vulva carcinoma are grouped by the kind of cells the cancer starts in, and that can affect how it looks and feels day to day. Symptoms don’t always look the same for everyone. Some types are more likely to cause an itchy patch or sore that does not heal, while others may appear as a dark spot, a lump, or bleeding from the vulva. Knowing the different types of vulva carcinoma can help explain why symptoms and growth patterns are not always the same.
Squamous cell
This is the most common type of vulva carcinoma and often starts in the thin skin covering the vulva. It may cause itching, burning, pain, or a patch, bump, or ulcer that does not go away. Some growths are raised and rough, while others look flat or sore.
Vulvar melanoma
This type begins in pigment-making cells and often appears as a dark brown, black, or unevenly colored spot. It may also itch, bleed, or change in size or shape over time. In some people, it can look like a new mole or a mole that is changing.
Adenocarcinoma
This type starts in gland cells, including glands near the vaginal opening such as the Bartholin gland. It may feel more like a deeper lump or swelling than a surface skin change. Some may notice tenderness, pressure, or a mass that seems to grow under the skin.
Basal cell
This is an uncommon type that usually grows slowly on the outer vulvar skin. It often looks like a small pearly bump, a pink patch, or a sore that keeps returning in the same spot. Pain is not always obvious at first, so it can be mistaken for a minor skin problem.
Verrucous carcinoma
This is a rare, slow-growing form of squamous cell cancer that often looks like a large wart-like growth. It may cause irritation, discharge, or discomfort from rubbing against clothing or during sitting and walking. It tends to spread locally more than it spreads to distant parts of the body.
Can I slow down the onset of symptoms?
No one can reliably slow or delay the start of symptoms from vulvar cancer once it is developing, but not smoking and getting the HPV vaccine are well-established ways to lower the risk of some types, and treating long-lasting vulvar skin problems or precancerous changes may also help. There is no routine screening test for everyone, but regular gynecology care and getting ongoing itching, pain, a lump, bleeding, or skin color changes checked early can help find problems sooner. These steps may reduce risk or lead to earlier treatment, but they cannot guarantee prevention, so the most helpful approach is staying alert to changes and seeking care promptly.
What genetics can tell you about symptoms
Genetics can sometimes explain why vulva carcinoma develops, but they usually do not predict the exact symptoms someone will notice day to day. Many living with vulva carcinoma have similar warning signs, such as itching, pain, burning, bleeding, or a lump or sore, regardless of the genetic changes involved, although certain tumor changes and whether the cancer is linked to HPV can affect how aggressive it is and, in some cases, how quickly symptoms appear. Inherited gene changes can raise risk in a small number of people, but they are not a reliable way to tell which symptoms will happen, how severe they will feel, or exactly when they will start.
Causes and risk factors
Vulva carcinoma, often called vulvar cancer, is more likely in older adults and in people with long-term vulvar skin problems such as lichen sclerosus. Infection with certain types of human papillomavirus, or HPV, is another major cause. Smoking and a weakened immune system can make these abnormal cell changes more likely. When doctors look at risk factors for vulvar cancer, it is rarely just one factor, and the mix matters. Most cases are not inherited, so family genes usually play a smaller role than HPV, skin disease, smoking, or immune problems.
What are the most common causes or risk factors?
The most common causes and risk factors for vulvar cancer include a long-lasting infection with certain types of HPV, a common virus spread through sexual contact, and long-term skin problems of the vulva that cause itching, irritation, or skin changes, especially as people get older. Risk is also higher in people who smoke, have a weakened immune system, or have had abnormal cell changes or cancer in the cervix, vagina, or vulva before. Inherited risk does not seem to be a major cause for most people, although a family history of related cancers may slightly raise risk in some families.
Environmental and biological risk factors
Vulva carcinoma is more likely in some people because of certain body-related conditions and long-term changes in the vulvar skin. Doctors often group risks into internal (biological) and external (environmental). For vulva carcinoma, the clearest known risks are mostly biological, and knowing the main risk factors for vulva carcinoma can help you know when a symptom deserves medical attention.
Vulva carcinoma becomes more common with age, especially after menopause. That is partly because abnormal cell changes have had more time to build up over the years.
A long-lasting infection with high-risk human papillomavirus, or HPV, can change vulvar cells over time. This is one of the main biological risk factors, especially when the infection does not clear on its own.
Precancerous areas in the vulva, sometimes called vulvar intraepithelial neoplasia, mean the cells are already abnormal. These changes can raise the chance of vulva carcinoma if they are not found and treated.
This long-term vulvar skin condition can cause thin, fragile, itchy, or scarred skin. In some people, the ongoing inflammation and skin damage increase the risk of cancer developing in that area.
Genetic risk factors
Most vulva carcinoma happens because gene changes build up in vulvar cells over time, not because a parent passed down a faulty gene. Carrying a genetic change doesn’t guarantee the condition will appear. Inherited risk for vulva carcinoma is uncommon, but it can matter in families with rare DNA repair disorders or several relatives with related cancers. These genetic risk factors for vulvar cancer are much less common than non-genetic causes, so many people with the disease have no family history at all.
Acquired mutations: Many vulva carcinomas start after gene changes develop in the vulvar tissue during life. These changes are usually not inherited and cannot be passed on to children. They can affect genes that normally repair damage or keep cell growth under control.
Inherited risk rare: A clearly inherited cause is uncommon in vulva carcinoma. Even when cancer seems to run in a family, that does not always mean there is a single faulty gene behind it.
Family history: Having several close relatives with vulvar or other gynecologic cancers can suggest a higher inherited risk. This matters more when cancers appeared at younger ages or in more than one generation.
Fanconi anemia: This rare inherited condition affects how the body repairs damaged DNA. People living with Fanconi anemia have a higher chance of some squamous cell cancers, including cancer of the vulva.
Lifestyle risk factors
Several habits can influence the chance of developing vulva carcinoma, mainly by affecting persistent HPV infection, local tissue irritation, and overall cancer risk. Smoking is the clearest lifestyle-related factor, while sexual behaviors that increase HPV exposure also matter. Excess body weight and low physical activity may contribute indirectly through chronic inflammation and related health effects. When people ask about lifestyle risk factors for vulva carcinoma, the strongest evidence points to smoking and HPV-related sexual exposure.
Tobacco use increases the risk of vulva carcinoma, especially HPV-related disease. Smoking can weaken local immune defenses and make it harder for the body to clear HPV infection.
Having unprotected sex or multiple sexual partners can increase exposure to high-risk HPV, which is linked to many vulvar cancers. Reducing HPV exposure through safer sex practices may lower risk over time.
Obesity and long-term physical inactivity may raise cancer risk indirectly through chronic inflammation and poorer metabolic health. They can also make skin irritation and vulvar discomfort harder to manage, which may complicate early symptom recognition.
Ongoing irritation from delayed care, chronic scratching, or poorly managed skin symptoms may allow abnormal vulvar changes to go unnoticed for longer. Seeking prompt evaluation of persistent itching, pain, or skin changes can support earlier detection.
Risk prevention
Vulva carcinoma cannot always be prevented, but there are clear ways to lower risk. For many, prevention centers on reducing long-term irritation, lowering the chance of certain infections, and catching cell changes early before cancer develops. Prevention works best when combined with regular check-ups. This matters because early symptoms of vulva carcinoma, such as lasting itching or a sore that does not heal, can be easy to dismiss.
The HPV vaccine can lower the risk of vulva carcinoma linked to high-risk HPV types. It works best before exposure to the virus, but some older teens and adults may still benefit after discussing it with a clinician.
Using condoms and limiting exposure to sexually transmitted infections can help reduce HPV spread, although condoms do not block all skin-to-skin contact. Regular sexual health care can also help identify concerns early.
Smoking makes it harder for the body to clear HPV and is linked to a higher risk of vulva carcinoma. Quitting can lower risk over time and also improves healing and overall health.
Ongoing vulvar skin problems, especially lichen sclerosus, should be treated and monitored because they can raise cancer risk. Using prescribed creams and keeping follow-up visits can help protect the skin from long-term damage.
Can you prevent Vulva carcinoma?
You cannot fully prevent vulva carcinoma, also called vulvar cancer, but some cases may be less likely with the right steps. The most helpful ways to lower risk are getting the HPV vaccine, not smoking, reducing the chance of HPV infection through safer sex, and getting ongoing care for lasting itching, skin changes, sores, or other long-term problems in the vulva area. Even with these steps, some people still develop this cancer, so it is important to have new or persistent symptoms checked.
Transmission
Vulva carcinoma is not infectious, so it cannot be passed from one person to another through sex, touching, kissing, shared towels, or toilet seats. Many people ask whether vulva carcinoma is contagious, but the cancer itself does not spread between people in any everyday or intimate contact.
Some cases of vulva carcinoma are linked to human papillomavirus, or HPV, and HPV can spread through intimate skin-to-skin sexual contact. Even so, this does not mean vulva carcinoma is transferred in the same way; it means an HPV infection may, over many years and only in some people, raise the risk of this cancer.
When to test your genes
For vulvar carcinoma, genetic testing is not usually used for early detection. It may be worth discussing if you have vulvar cancer plus a strong family history of cancer, several relatives with related cancers, or unusually early cancers, because that can sometimes point to an inherited cancer syndrome.
Diagnosis
Changes in the vulva, such as a sore that does not heal, itching that keeps coming back, bleeding, or a new lump, are often what first lead to testing for vulva carcinoma. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of vulva carcinoma usually starts with a careful exam and then moves to tests that confirm whether cancer cells are present and whether the disease has spread.
A doctor examines the vulva closely and may also check the vagina, cervix, and nearby skin for unusual areas. They look for sores, thickened patches, color changes, or lumps that could need further testing.
A small sample of tissue is taken from the abnormal area and examined under a microscope. This is the main test used to confirm vulva carcinoma and tell it apart from noncancerous skin conditions.
Doctors feel the groin area to see whether nearby lymph nodes seem enlarged or firm. This can give early clues about whether vulva carcinoma may have spread beyond the original spot.
If cancer is confirmed or strongly suspected, scans such as ultrasound, CT, MRI, or PET may be used to look more closely at the pelvis and nearby tissues. These tests help show the size of the tumor and whether lymph nodes or other organs are involved.
How is Vulva carcinoma diagnosed?
Vulva carcinoma, also called vulvar cancer, is usually diagnosed after a doctor asks about symptoms and does an exam to closely check any sore, lump, skin change, or area that is not healing on the vulva. The diagnosis is confirmed with a biopsy, which means taking a small sample of tissue and looking at it under a microscope to see if cancer cells are present. If cancer is found, imaging tests such as ultrasound, CT, MRI, or PET scans, and sometimes checks of nearby lymph nodes, help show whether it has spread; genetic testing is not usually the main way this cancer is diagnosed.
Stages of Vulva carcinoma
Vulvar carcinoma is usually described by stages based on how large the cancer is and whether it has spread to nearby tissues, lymph nodes, or farther parts of the body. This matters in daily life because stage often shapes treatment choices, recovery time, and what to expect next. Early and accurate diagnosis helps you plan ahead with confidence, especially if early symptoms of vulvar carcinoma such as itching, soreness, or a persistent skin change led to testing.
Stage 1
The cancer is only in the vulva or perineum, the area between the vaginal opening and anus. It has not spread to nearby lymph nodes or distant parts of the body.
Stage 2
The cancer has grown into nearby structures such as the lower urethra, lower vagina, or anus. It still has not spread to nearby lymph nodes or distant organs.
Stage 3
The cancer may be any size and has spread to nearby groin lymph nodes. Some people at this stage also have tumor growth into nearby tissues, but there is still no spread to distant organs.
Stage 4
The cancer has spread more widely into the upper urethra, upper vagina, bladder, rectum, pelvic bone, or to lymph nodes that are fixed or ulcerated. In the most advanced stage, vulvar carcinoma has spread to distant parts of the body such as the lungs or liver.
Outlook and prognosis
Outlook for vulvar carcinoma depends mainly on the stage at diagnosis, tumor size, lymph node involvement, and whether the cancer can be completely removed with treatment. When found early and confined to the vulva, prognosis is often favorable, with 5-year survival commonly around 80% to 90%, whereas survival drops substantially when cancer has spread to groin or pelvic lymph nodes or to distant organs. Lymph node metastasis is one of the strongest predictors of recurrence and mortality. Many patients can be cured with surgery, sometimes combined with radiation therapy and chemotherapy, but advanced or recurrent disease is harder to control and may require long-term treatment. Older age, frailty, and treatment complications can also affect outcomes, especially because vulvar cancer often occurs in later life. Careful follow-up is important because recurrences may occur, particularly within the first 2 years after treatment.
Long-term effects
For many living with vulva carcinoma, the long-term picture depends a lot on the stage of the cancer, the treatment used, and whether it comes back after treatment. Many do well, especially when vulva carcinoma is found early, but some may face lasting changes in comfort, movement, bladder or bowel function, and sexual health. Thinking about the long-term effects helps set realistic expectations and can make follow-up care feel more purposeful.
One of the main long-term concerns is that vulva carcinoma can return in the vulva, nearby lymph nodes, or less often in other parts of the body. The risk is usually higher in the first few years after treatment, which is why regular checkups matter.
Surgery can leave scarring, tightness, numbness, or ongoing tenderness in the vulvar area. For many, this can mean discomfort with sitting, walking, exercise, or wearing certain clothes.
Treatment may affect body image, arousal, and comfort during sex, especially if tissue has been removed or treated with radiation. Many people with vulva carcinoma notice that dryness, pain, or fear of pain can continue long after treatment ends.
If lymph nodes in the groin are removed or treated with radiation, fluid can build up and cause swelling in the legs or genital area. This swelling, called lymphedema, can feel heavy, tight, or uncomfortable and may become a long-term issue.
How is it to live with Vulva carcinoma?
Living with vulva carcinoma can touch some of the most private parts of daily life, often affecting comfort, body image, intimacy, sitting, walking, exercise, and even routine things like using the bathroom or wearing certain clothes. Many living with vulva cancer also carry an emotional load, with worry about treatment, recurrence, sexual health, and how their body may change, but the experience varies widely depending on the stage of the cancer and the type of treatment. For partners, family, and close friends, this can mean stepping into practical caregiving, offering emotional support, and adjusting to changes in intimacy and routines, yet clear communication and supportive care can help people feel less alone and more in control.
Treatment and drugs
Treatment for vulva carcinoma depends on how large the cancer is, where it is on the vulva, whether it has spread, and your overall health, but surgery is often the main treatment. Depending on the stage, this may mean removing only the cancer and a small rim of nearby tissue, or a larger operation, and doctors may also check or remove nearby lymph nodes in the groin to see if cancer cells have traveled there. Treatment plans often combine several approaches, so some people with vulva carcinoma also have radiation therapy, chemotherapy, or both, either before surgery to shrink the cancer or after surgery to lower the chance of it coming back. In some cases, drug treatment is used for more advanced disease or when surgery is not the best option, and care may also include pain control, wound care, and support with sexual health and daily comfort. Finding the right therapy can take some time, and if you are looking into the best treatment options for vulva carcinoma, a gynecologic cancer specialist can help explain the choices in a way that fits your situation.
Can you cure Vulva carcinoma?
Vulva carcinoma, also called vulvar cancer, can sometimes be cured, especially if it is found early and treated quickly. Treatment often includes surgery, and some people also need radiation or cancer-fighting medicines to remove or destroy the cancer. If the cancer has spread or comes back, treatment may not cure it, but it can still help shrink it, slow it down, and relieve symptoms.
Non-drug treatment
Treatment for vulva carcinoma often centers on procedures and supportive care rather than medicines alone. For many, treatment begins not at the pharmacy, but with surgery to remove the cancer while preserving as much healthy tissue as possible. Depending on the tumor size, depth, and whether nearby lymph nodes are involved, radiation and other specialist treatments may also be used. Supportive therapies can also help with pain, wound healing, mobility, bladder or bowel comfort, and sexual well-being during recovery.
Surgery is the main non-drug treatment for vulva carcinoma and is often used first. The aim is to remove the cancer with a rim of healthy tissue while keeping normal function as much as possible. Some people need a smaller local operation, while others need a wider procedure depending on the cancer’s size and location.
Doctors may also examine or remove groin lymph nodes to see if the cancer has spread. This can be done with a sentinel node procedure or with removal of more nodes when risk is higher. The results help guide the rest of treatment.
Radiation uses carefully targeted high-energy beams to treat the tumor or lower the chance of it coming back after surgery. It may be used when surgery would be too extensive, when lymph nodes are involved, or when surgical margins are not clear. Skin soreness, fatigue, and irritation in the treated area can often be managed with supportive care.
Sometimes radiation is combined with chemotherapy to make the radiation work better, especially for more advanced vulva carcinoma. Even though this includes medicine, the radiation-based plan is a key non-drug part of treatment. It may help shrink a tumor before surgery or treat cancer that cannot be fully removed at first.
Your genes may have an impact on how drugs work for you
Small differences in the genes people are born with can sometimes change how their body breaks down certain medicines used during vulvar cancer care, including some pain drugs, anti-nausea medicines, and cancer treatment drugs, so one person may get good relief while another has stronger side effects or needs a different dose. This kind of gene-guided prescribing, called pharmacogenomics, is not a routine part of treatment for most people with vulvar cancer, but it may be considered in some situations if side effects are unusual or a medicine does not seem to work as expected. For many living with vulvar cancer, doctors still choose treatment mainly based on the cancer itself, overall health, and how someone responds once treatment starts.
Pharmacological treatments
Drug treatment for vulva carcinoma is most often used when the cancer is advanced, has come back, or is being treated together with radiation. Surgery is still the main treatment for many people, but medicines can help shrink cancer, control symptoms, or lower the chance of spread in selected cases. Medication can feel like a big step, but the exact plan depends on the stage, the tumor type, and your overall health.
Cisplatin is one of the most commonly used drugs for vulva carcinoma, especially when it is given with radiation. In this setting, it helps radiation work better against the cancer. It may also be used in some advanced or recurrent cases.
Carboplatin and paclitaxel are chemotherapy drugs often used together when vulva carcinoma has spread, cannot be removed fully with surgery, or has returned after earlier treatment. For many, this can mean treatment for advanced vulva carcinoma aimed at slowing growth and easing symptoms. Doctors may choose this pair when a broader whole-body treatment is needed.
Fluorouracil, often called 5-FU, may be used with cisplatin in some treatment plans for vulva carcinoma. This is less common than some newer chemotherapy combinations, but it is still a recognized option in certain centers and clinical situations.
Pembrolizumab is an immunotherapy drug that may be offered for some people with recurrent or metastatic vulva carcinoma, especially if the tumor has certain biomarker results. It helps the immune system recognize and attack cancer cells more effectively. Not everyone responds to the same medication in the same way.
Genetic influences
After a diagnosis of vulva carcinoma, many people start wondering what it might mean for daughters, sisters, or other close relatives. In most cases, vulva carcinoma is not strongly inherited, and the gene changes linked to it arise over time in the vulvar cells rather than being present from birth. Some cases are more closely tied to long-term human papillomavirus (HPV) infection, while others develop along with chronic vulvar skin conditions and acquired changes in genes that normally keep cell growth under control. Family history is one of the strongest clues to a genetic influence. If there is a strong family history of vulva carcinoma, several cancers in close relatives, or cancer appearing at a younger age than expected, your doctor may suggest genetic counseling to look for a rare inherited cancer syndrome. Even then, the goal is not to predict the future with certainty, but to use that information to guide prevention, follow-up, and family conversations.
Is Vulva carcinoma genetic?
Genetics matter in vulva carcinoma, but most cases are not strongly inherited. Some gene changes in the tumor can help guide treatment, while inherited risk is usually limited and only becomes more relevant when there is a strong family history.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a normal part of being human and are found in many people. Most of these changes do not directly affect health and are simply part of normal human variation. For many genes, having a change linked to a condition suggests a possible connection rather than a certain diagnosis, especially when several genes and environmental factors also play a role. In some cases, though, one well-understood change in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
In vulva carcinoma, genetics can matter in two different ways: changes inside the tumor may help shape treatment choices, and your own inherited genes may affect how your body handles certain medicines. Genes can influence how quickly you break down some chemotherapy drugs and supportive medicines, which can change the chance of side effects or how well a drug works. In advanced or recurrent vulva carcinoma, doctors may sometimes test the cancer for specific markers to see whether immune therapy or a targeted drug could be an option, although this does not help in every case. For many living with vulva carcinoma, the biggest treatment decisions still depend more on the cancer’s stage, exact location, and overall health than on genetics alone. Not every difference in response is genetic, but if treatment causes unusual side effects or does not work as expected, your care team may consider whether genetic testing for vulva carcinoma treatment could add useful information.
Interactions with other conditions
Having more than one diagnosis can make symptoms feel harder to untangle. For people living with vulva carcinoma, other conditions can affect both how the cancer is found and how treatment is managed. Long-standing skin disorders of the vulva, such as lichen sclerosus, can raise the risk of some cases and may make early symptoms of vulva carcinoma easier to miss because itching, soreness, or skin changes can seem familiar at first. In older adults, heart disease, lung disease, diabetes, or kidney problems may limit which surgery, radiation, or medicines are safest, and they can also slow recovery. Some may also have cervical, vaginal, or anal precancer or cancer linked to the same human papillomavirus, so doctors may check nearby areas carefully rather than looking at the vulva alone. If the immune system is weakened, including after an organ transplant or with HIV infection, vulva carcinoma may be more likely to develop and follow-up often needs to be especially close.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Vulva carcinoma?
Symptoms of vulva carcinoma, such as itching, burning, pain, a lump, or skin color changes, can also happen with more common conditions like yeast or other skin infections, eczema, a long-term skin condition called lichen sclerosus, genital warts, or a blocked gland that forms a cyst near the vaginal opening. Some harmless skin growths in this area can look similar as well. Because these problems can overlap, any sore, lump, bleeding, or itching that does not go away should be checked by a doctor.
History
Across cultures and time periods, people have described long-lasting vulvar sores, growths, or bleeding that would now often raise concern for vulva carcinoma. In earlier centuries, these problems were usually grouped with many other skin or genital conditions, so doctors did not always recognize them as a separate cancer. For women living with these symptoms, this often meant delays in diagnosis, especially when changes were hidden, embarrassing to mention, or mistaken for irritation or infection.
As medical science evolved, doctors became better at linking certain visible changes of the vulva with cancer. By the late 1800s and early 1900s, pathology, the study of tissue under a microscope, made it possible to tell vulva carcinoma apart from other vulvar diseases more reliably. This mattered in everyday life: someone with itching that would not go away, a sore that kept returning, or a lump that slowly enlarged could finally have the area examined and identified more accurately.
Treatment also changed over time. Earlier care was often limited and could be very extensive, with large operations used because the disease was usually found late. Over the 20th century, surgery became more targeted, and doctors learned more about when to add radiation or other treatments. In recent decades, awareness has grown around early symptoms of vulva carcinoma, including persistent itching, pain, skin color changes, or a lesion that does not heal, which has helped some people get checked sooner.
Researchers also came to understand that vulva carcinoma is not always one single pathway of disease. Some cases are linked to long-term skin conditions of the vulva, while others are connected to certain infections and later cellular changes. More recent research has improved screening of suspicious lesions, refined staging, and supported more personalized care. Today, the history of vulva carcinoma reflects a steady shift from vague descriptions and late recognition toward earlier diagnosis, clearer classification, and treatment plans that aim to control the cancer while preserving quality of life as much as possible.